BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12857729)

  • 1. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway.
    Yun J; Chae HD; Choi TS; Kim EH; Bang YJ; Chung J; Choi KS; Mantovani R; Shin DY
    J Biol Chem; 2003 Sep; 278(38):36966-72. PubMed ID: 12857729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions.
    Chae HD; Yun J; Bang YJ; Shin DY
    Oncogene; 2004 May; 23(23):4084-8. PubMed ID: 15064732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p21 with NF-YA suppresses the expression of Polo-like kinase 1 and prevents mitotic death in response to DNA damage.
    Lin YC; Chen YN; Lin KF; Wang FF; Chou TY; Chen MY
    Cell Death Dis; 2014 Jan; 5(1):e987. PubMed ID: 24407240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
    Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
    Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-Y binds to both G1- and G2-specific cyclin promoters; a possible role in linking CDK2/Cyclin A to CDK1/Cyclin B.
    Chae HD; Kim J; Shin DY
    BMB Rep; 2011 Aug; 44(8):553-7. PubMed ID: 21871181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
    Narayanan R; Adigun AA; Edwards DP; Weigel NL
    Mol Cell Biol; 2005 Jan; 25(1):264-77. PubMed ID: 15601848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of cyclin A and cyclin kinase inhibitor p21 in response to gamma-irradiation requires the CDK2 binding region, but not the Cy motif.
    Fukuchi K; Nakamura K; Ichimura S; Tatsumi K; Gomi K
    Biochim Biophys Acta; 2003 Oct; 1642(3):163-71. PubMed ID: 14572899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus IE63 protein phosphorylation by roscovitine-sensitive cyclin-dependent kinases modulates its cellular localization and activity.
    Habran L; Bontems S; Di Valentin E; Sadzot-Delvaux C; Piette J
    J Biol Chem; 2005 Aug; 280(32):29135-43. PubMed ID: 15955820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH; Kang KH; Kim MY; Choi KH
    Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
    Zhu H; Nie L; Maki CG
    J Biol Chem; 2005 Aug; 280(32):29282-8. PubMed ID: 15964852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of beta-catenin phosphorylation/degradation by cyclin-dependent kinase 2.
    Park CS; Kim SI; Lee MS; Youn CY; Kim DJ; Jho EH; Song WK
    J Biol Chem; 2004 May; 279(19):19592-9. PubMed ID: 14985333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRE-transcription factor decoy oligonucleotide inhibition of MCF-7 breast cancer cells: cross-talk with p53 signaling pathway.
    Lee YN; Park YG; Choi YH; Cho YS; Cho-Chung YS
    Biochemistry; 2000 Apr; 39(16):4863-8. PubMed ID: 10769144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinases phosphorylate human Cdt1 and induce its degradation.
    Liu E; Li X; Yan F; Zhao Q; Wu X
    J Biol Chem; 2004 Apr; 279(17):17283-8. PubMed ID: 15004027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.